Though experts may disagree on when earth’s supply of fossil fuels will be exhausted, they do agree that it will happen eventually. After all, fossil fuels typically require millions of years of degradation to create. So the race for alternative biofuels is on.
The Department of Energy (DOE) recently awarded the Washington University, St. Louis (WUSTL) $3.9 in research funding to develop bacteria that manufactures renewable biofuels. WUSTL scientists are studying Rhodococcus opacus, a bacteria that grows on toxic compounds, using them as a source of food for the production of biofuels. The goal of this research project is to produce biofuels that can completely replace petroleum-based fuels.
Read More
Tags:
Washington University St. Louis,
Bioresearch funding,
Biotechnology vendor show,
Washington University,
WUSTL,
Renewable Energy,
biofuels,
laboratory equipment suppliers,
NIH award,
BioResearch Product Faire,
Department of Energy,
life scinece,
life science labs,
Biotechnology trade show,
Reproductive Research
According to the National Cancer Institute (NCI) there are over 380,000 people living with leukemia in the United States. Each year roughly 24,500 people die from the disease and over 62,000 new cases are diagnosed. To improve treatment options for leukemia patients, the NCI recently awarded John DiPersio, MD, PhD of Washington University, St. Louis $6 million in research funding. The Professor of Medicine in Oncology at the university’s School of Medicine will use the seven years of funding to support three major areas of leukemia research in his lab. These include: improving the effectiveness of standard chemotherapy, preventing graft-versus-host disease, and developing new immunotherapies.
Read More
Tags:
Washington University St. Louis,
Washington University,
WashU,
WUSTL,
Leukemia,
cancer research,
Cancer,
Research Funding,
biotech vendor show,
cancer research funding,
Bioresearch Grant,
Biotechnology trade show,
NIH awards 2017,
Cancer Therapeutics,
Cancer Immunotherapy
The Biotechnology Calendar, Inc. BioResearch Product Faire™ will be returning to Washington University, St. Louis for its 19th Annual event. WashU's Life Science R&D Expenditures and NIH funding has been totaling about $1 Billion the past few years proving the University's dedication to being at the forefront of life science research and providing a prime opportunity for boosting scientific sales.
Read More
Tags:
Washington University St. Louis,
Washington University,
WashU,
MO,
St Louis,
2018
Washington University in St. Louis has 1 of 57 Institutes of Clinical and Translation Sciences (ICTS) in the United States. The ICTS at Washington University focuses on translating discoveries from both translation and clinical research into new treatments and therapies. The ICTS does not focus on just one area of life science research. Instead, researchers from all spectrums on the health sciences are able to use the institutes resources to further their work on topics like disease prevention and treatment. Training programs are also offered through the institute for researchers. (Image courtesy of P. David via Wikimedia Commons)
Read More
Tags:
Washington University St. Louis,
WashU,
BioResearch Product Faire Event,
MO,
NIH funding,
Clinical and Translational Research,
2018,
clinical and translational research funding
The National Institute of Health (NIH) awarded Washington University in St. Louis over $1.4 million in grant funding to support their School of Medicine’s Diabetic Research Center. This award was administered through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as it has been for the last 38 years. The funding will help support the Diabetic Research Center (DRC) and their life science labs. The DRC's mission is to “support and enhance research in diabetes and related metabolic diseases” through Biomedical Research Core services as well as the Pilot and Feasibility Program.
Read More
Tags:
Washington University St. Louis,
Bioresearch funding,
Biotechnology vendor show,
Washington University,
WUSTL,
Diabetes,
NIH award,
life scinece,
life science labs,
Biotechnology trade show
Washington University School of Medicine in St. Louis is leading an international team studying potential treatments to prevent Alzheimer’s disease. The team recently added a third medicationin this worldwide clinical trial that is already underway. According to the WU School of Medicine news site, the latest investigational drug “is designed to lower production of amyloid beta, a protein that clumps together into plaques damaging neurons in the brain, leading to memory loss, cognitive problems and confusion.”
Read More
Tags:
Washington University St. Louis,
Washington University,
WUSTL,
Alzheimer' Research,
Alzheimer’s,
Research Funding,
biotech vendor show,
Alzheimer's treatment market,
Bioresearch Grant,
Biotechnology trade show
Despite recent advances in neuroimaging, the medical community still lacks a comprehensive map of the brain and how it changes with age. Such maps would make it possible for doctors to distinguish between what is normal aging and what is atypical, which would make it possible to link atypical changes to neurological diseases and various mental health issues. Thanks to a $34 million NIH grant, Washington University School of Medicine in St. Louis will lead a project to make such maps of the brain a reality.
Read More
Tags:
Washington University St. Louis,
WUSTL,
Biotechnology Vendor Fair,
Research Funding,
NIH grant,
laboratory equipment sales,
research grants
A team of researchers led by Gaya Amarasinghe, associate professor of Pathology and Immunology at Washington University School of Medicine, was recently awarded a $13 million NIH grant to study the replication process of the Ebola virus.
Read More
Tags:
Washington University St. Louis,
Research Funding,
MO,
NIH grant,
Midwest Region,
ebola
The National Institutes of Health (NIH) recently launched a new network of institutions - called the Centers for Common Disease Genomics (CCDG) - which will study common conditions such as heart disease, stroke, diabetes, and autism to see how genetics and DNA contribute to the risk of these diseases. The McDonnell Genome Institute at Washington University in St. Louis is one of four institutions involved in this network and will be receiving $60 million over the next four years to study genomics and common diseases.
Read More
Tags:
Washington University St. Louis,
Midwest,
Missouri,
WashU,
heart disease,
Diabetes,
Autism,
BioResearch Product Faire Event,
MO,
St Louis,
NIH funding,
2016,
Centers for Common Disease Genomics,
stroke,
CCDG
For years, we’ve been discussing reasons not to use antibiotics and have seen the development of new alternatives, such as spray-on antibodies and internal bacterial combustion. Despite this, antibiotics continue to be widely used today. Scientists at Washington University in St. Louis theorize that antibiotics are here to stay, but perhaps it is the definition of antibiotics that needs to be changed.
Read More
Tags:
Washington University St. Louis,
WashU,
BioResearch Product Faire Event,
MO,
St Louis,
2016
